JP7449626B2 - スクリーニング方法に使用するためのヒト脂肪肝モデル細胞 - Google Patents

スクリーニング方法に使用するためのヒト脂肪肝モデル細胞 Download PDF

Info

Publication number
JP7449626B2
JP7449626B2 JP2023502465A JP2023502465A JP7449626B2 JP 7449626 B2 JP7449626 B2 JP 7449626B2 JP 2023502465 A JP2023502465 A JP 2023502465A JP 2023502465 A JP2023502465 A JP 2023502465A JP 7449626 B2 JP7449626 B2 JP 7449626B2
Authority
JP
Japan
Prior art keywords
cells
vldl
medium
human
fatty liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023502465A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022181660A1 (https=
JPWO2022181660A5 (https=
Inventor
真生 高橋
雅和 加国
奈美 吉川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phoenixbio Co Ltd
Original Assignee
Phoenixbio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoenixbio Co Ltd filed Critical Phoenixbio Co Ltd
Publication of JPWO2022181660A1 publication Critical patent/JPWO2022181660A1/ja
Publication of JPWO2022181660A5 publication Critical patent/JPWO2022181660A5/ja
Application granted granted Critical
Publication of JP7449626B2 publication Critical patent/JP7449626B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2023502465A 2021-02-26 2022-02-24 スクリーニング方法に使用するためのヒト脂肪肝モデル細胞 Active JP7449626B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021030911 2021-02-26
JP2021030911 2021-02-26
PCT/JP2022/007494 WO2022181660A1 (ja) 2021-02-26 2022-02-24 スクリーニング方法に使用するためのヒト脂肪肝モデル細胞

Publications (3)

Publication Number Publication Date
JPWO2022181660A1 JPWO2022181660A1 (https=) 2022-09-01
JPWO2022181660A5 JPWO2022181660A5 (https=) 2023-07-13
JP7449626B2 true JP7449626B2 (ja) 2024-03-14

Family

ID=83049072

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502465A Active JP7449626B2 (ja) 2021-02-26 2022-02-24 スクリーニング方法に使用するためのヒト脂肪肝モデル細胞

Country Status (6)

Country Link
US (1) US20250263667A1 (https=)
EP (1) EP4299720A4 (https=)
JP (1) JP7449626B2 (https=)
CN (1) CN116917462A (https=)
CA (1) CA3211975A1 (https=)
WO (1) WO2022181660A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023058657A1 (ja) * 2021-10-04 2023-04-13 株式会社フェニックスバイオ コレステロール不含の高比重リポタンパク質粒子

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014204713A (ja) 2013-03-21 2014-10-30 秋田県 肝細胞分化ステージを評価する新規測定法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3157984B2 (ja) 1994-04-11 2001-04-23 科学技術振興事業団 初代培養肝細胞の継代培養系
CA2146735C (en) 1994-04-11 2007-02-20 Chise Tateno Liver parenchymal cells having clonal growth ability, method for obtaining same, method for subculturing same, and subculturing system of primary hepatocytes
JP3266766B2 (ja) 1994-08-23 2002-03-18 科学技術振興事業団 ローン性増殖能を有する肝実質細胞とその取得方法、並びにその継代培養方法
JPH0915225A (ja) 1995-04-28 1997-01-17 Tosoh Corp 血清リポタンパク質の分析方法
JP3014322B2 (ja) 1996-05-28 2000-02-28 科学技術振興事業団 小型肝細胞の培養方法
JP3211941B2 (ja) 1996-12-26 2001-09-25 科学技術振興事業団 ヒト小型肝細胞の取得方法と、この細胞の初代培養および継代培養方法
JP2002045087A (ja) 2000-05-19 2002-02-12 Japan Science & Technology Corp キメラ動物
JPWO2007052789A1 (ja) 2005-11-04 2009-04-30 株式会社スカイライト・バイオテック 大血管障害を判別するためのリポタンパク質の分析方法
JP2007228962A (ja) 2006-01-31 2007-09-13 Hiroshima Industrial Promotion Organization ヒト肝細胞キメララットの作製方法
WO2008001614A1 (fr) 2006-06-29 2008-01-03 Hiroshima Industrial Promotion Organization Modèle animalier de stéatohépatite non alcoolique et modèle animalier de stéatose hépatique
AU2012374750B2 (en) 2012-03-27 2017-02-02 National University Corporation Kumamoto University Humanized mouse
KR102089477B1 (ko) * 2012-08-31 2020-03-17 더 가버너스 오브 더 유니버시티 오브 알버타 1차 인간 간세포의 표현형을 갖는 세포를 생성하기 위한 방법 및 조성물
WO2016210163A1 (en) * 2015-06-23 2016-12-29 Colorado State University Research Foundation Engineered model of fibrotic diseases
JP7039045B2 (ja) * 2019-08-26 2022-03-22 株式会社フェニックスバイオ ヒト脂肪肝モデル細胞
JP7379934B2 (ja) 2019-08-26 2023-11-15 マツダ株式会社 車両の後部構造

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014204713A (ja) 2013-03-21 2014-10-30 秋田県 肝細胞分化ステージを評価する新規測定法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BIOMEDICAL RESEARCH (TOKYO)，2020年02月01日，Vol. 41, No. 1，pp. 33-42
J. Biol. Macromol.，2021年01月20日，Vol. 21, No. 1，pp. 51-52

Also Published As

Publication number Publication date
US20250263667A1 (en) 2025-08-21
CA3211975A1 (en) 2022-09-01
CN116917462A (zh) 2023-10-20
EP4299720A4 (en) 2025-03-05
JPWO2022181660A1 (https=) 2022-09-01
EP4299720A1 (en) 2024-01-03
WO2022181660A1 (ja) 2022-09-01

Similar Documents

Publication Publication Date Title
JP7039045B2 (ja) ヒト脂肪肝モデル細胞
JP7263455B2 (ja) 機能性ミトコンドリアで富化された哺乳動物細胞
Zs et al. Application of rabbits in biomedical research: a review.
Adigbli et al. Humanization of immunodeficient animals for the modeling of transplantation, graft versus host disease, and regenerative medicine
CN1146712A (zh) 哺乳动物疾病的成肌细胞治疗方法
CN103865871A (zh) 治疗肾功能衰竭的选择性细胞疗法
WO2008001614A1 (fr) Modèle animalier de stéatohépatite non alcoolique et modèle animalier de stéatose hépatique
US20090053200A1 (en) Method for retarding unhealth manifestations brought by ageing of human beings
JP6496107B2 (ja) 高尿酸血症モデル
Szczerba et al. In vitro culture of chicken circulating and gonadal primordial germ cells on a somatic feeder layer of avian origin
JP7449626B2 (ja) スクリーニング方法に使用するためのヒト脂肪肝モデル細胞
CN109234278B (zh) 构建ApoC2基因敲除仓鼠模型的试剂盒和方法
Qiao et al. CRISPR/Cas9 establishment-mediated targeted mutagenesis in Macrobrachium nipponense
Zheng et al. Novel organic selenium source hydroxy-selenomethionine counteracts the blood-milk barrier disruption and inflammatory response of mice under heat stress
JP2025098090A (ja) コレステロール不含の高比重リポタンパク質粒子
CN114164249B (zh) 一种筛选抑制肠道脂肪酸摄取及防治脂肪肝的药物靶点及其应用
CN107638428A (zh) 用于治疗肥胖症和/或代谢综合征的方法
Fan et al. Production of zebrafish germline chimeras from cultured cells
KR102174851B1 (ko) Cep41 유전자 결손 제프라피쉬 모델, 이의 용도 및 이를 이용한 치료제 스크리닝 방법
Lin et al. Xenotransplantation of Human Umbilical Mesenchymal Stromal Cells Derived from Wharton's Jelly Mitigates Mouse Amyotrophic Lateral Sclerosis
JP2024145886A (ja) 高比重リポタンパク質粒子の機能促進剤のスクリーニング方法
CN119367283A (zh) 一种脐带间充质干细胞注射液的制备方法
CN120814515A (zh) 胰腺导管内乳头状黏液性肿瘤模型小鼠及其肿瘤细胞的制备方法和应用
Noah Differences in lean and obese skeletal muscle myoblasts of adult and post-natal LA/N (faf) rats: a confocal description of the skeletal muscle myoblast
Zhang et al. Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230509

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230509

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230509

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230704

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231215

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240130

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240226

R150 Certificate of patent or registration of utility model

Ref document number: 7449626

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150